Allergy Diagnostics Market
An allergy is a hyperimmune response to certain products or substances. Allergies occur when a person’s immune system reacts to mild substances present in the environment. There are various different types of allergies, such as skin allergy, food allergy, dust allergy, pollen allergy, etc. These allergies can be fatal to a person under certain circumstances if left untreated. Various procedures that are used for allergy testing include blood tests, skin tests, etc., which helps healthcare professionals to provide treatment and instant relief to patients. Food allergy is caused due to the consumption of some proteins that may lead to discomfort and digestive problems. Drug allergy is caused due to the ingredients of some drugs that may reflect in the form of rashes, swelling, etc. These diagnostics help in the determination of allergic reactions and their treatment options. Some of the most commonly used diagnostics tests are intradermal, patch, prick, skin, and blood tests.
The major factor that contributes to the growth of the global allergy diagnostics market is the increased prevalence of allergy among people. As per Allergy UK 2015, around 20% of allergy patients live with a severe devastating form of their condition and fight with the distress of a most likely anaphylactic shock, asthma attack, or even death from an allergic reaction daily. Tremendous population rise is expected to increase allergic cases in the future. Furthermore, changing food habits, increasing geriatric population, favorable reimbursement scenario in developed economies, and rising awareness among people are expected to promote the global allergy diagnostics market. Moreover, increased healthcare expenditure and infrastructure coupled with changing lifestyles of people are also expected to boost the allergy diagnostic market globally over the forecast time period. On the other hand, various technological advancements are expected to create new growth opportunities for the growth of the allergy diagnostics market. However, the high cost and stringent regulatory approval process may inhibit the global allergy diagnostics market over the forecast time period.
The global allergy diagnostics market is categorized into product type, allergen type, and end-user. By product type, the allergy diagnostics market is segmented into luminometers, assay kits, immunoassay and ELISA analyzers, and services. Assay kits are expected to dominate the market in the future. By allergen type, the allergy diagnostics market is fragmented into inhaled, food, and others. Inhaled allergens are expected to dominate the allergy diagnostics market. By end-user, the allergy diagnostics market is segmented into hospitals, diagnostic laboratories, academic research institutes, and others. The hospitals segment is expected to develop rapidly over the estimated timeframe.
By region, North America is projected to lead the global allergy diagnostics market followed by Europe over the estimated timeframe. The Asia Pacific is expected to be the fastest developing region over the forecast period.
Some major players of the global allergy diagnostics market are Alerchek Inc., Stallergenes SA, DST Diagnostische Systeme & Technologien GmbH, Lincoln Diagnostics Inc., Hitachi chemical Diagnostic Inc., Siemens Healthcare Diagnostics, Inc., BioMerieux, Inc., Hycor Biomedical Inc., Danaher Corp., HOB Biotech Group Co. Ltd., Omega Diagnostic, and Thermo Fisher Scientific Inc., among others.